The HER2 receptor is a 195-k Da transmembrane glycoprotein with tyrosine kinase activity, and belongs in the human epidermal growth factor receptor (HER) family consisting of four members. Moreover, aberrant HER2 protein overexpression has been linked to various human gynecological adenocarcinomas, including breast, endometrium, ovary and cervix, and has been found to be a poor prognostic factor for survival. This new book presents topical research in the study of HER2, including targeting HER2 with photodynamic therapy; HER2 shedding as a biomarker in breast cancer; development of trastuzumab resistance and targeted nanomedicines conjugated with HER2 antibodies in cancer therapy.
€379.15
购买此电子书可免费获赠一本！
格式 PDF ● 网页 257 ● ISBN 9781611222746 ● 编辑 Christopher E. Rogers & Sophie I Williams ● 出版者 Nova Science Publishers ● 发布时间 2017 ● 下载 3 时 ● 货币 EUR ● ID 7218189 ● 复制保护 Adobe DRM
需要具备DRM功能的电子书阅读器
来自同一作者的更多电子书 / 编辑
9,192 此类电子书
